Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

29QJ

Respiratory syncytial virus fusion protein N-terminal heptad repeat domain in complex with Double stapled peptide 4/4g

Summary for 29QJ
Entry DOI10.2210/pdb29qj/pdb
DescriptorFusion glycoprotein F1, Double stapled peptide 4/4g (3 entities in total)
Functional Keywordshuman respiratory syncytial virus, fusion protein, fusion inhibitor, stapled peptide, six helix bundle, complex, antiviral protein, viral protein
Biological sourceHuman respiratory syncytial virus A
More
Total number of polymer chains2
Total formula weight8028.50
Authors
Duquerroy, S.,Nyanguile, O.,Gsponer, N. (deposition date: 2026-03-30, release date: 2026-06-10)
Primary citationPidoux, N.,Roh, L.,Nicolet, N.,Marti, R.,Le Rouzic, A.,Prompt, C.,Fix, J.,Duquerroy, S.,Rey, F.,Rameix-Welti, M.A.,Keck, M.,Barbe, P.,Garcin, D.,Mottet-Osman, G.,Larcher, T.,Galloux, M.,Nyanguile, O.
Double-Stapled Peptide Scan Yields Potent Fusion Inhibitors of Respiratory Syncytial Virus.
J.Med.Chem., 2026
Cited by
PubMed Abstract: Respiratory syncytial virus infection (RSV) is a major global health concern, particularly in infants and elderly populations. In this work, we have screened and identified 3 double-stapled peptides derived from a minimal domain of the RSV F heptad repeat, namely , , and , which are potent inhibitors of RSV fusion and remain active against viral escape mutants resistant to small-molecule fusion inhibitors. Our structural activity relationship (SAR) analysis demonstrates that combining a limited set of staples is sufficient to achieve high antiviral potency. X-ray crystallography revealed that the enhanced potency of and primarily arises from strong hydrophobic interactions between the N-terminal staple and the trimeric HR1 coiled coil of RSV F. pharmacokinetic, imaging, and feasibility studies in RSV-infected Balb/c mice further support intranasal administration as a promising route for delivering these stapled peptides to the lung, highlighting their potential as therapeutics against RSV.
PubMed: 42203199
DOI: 10.1021/acs.jmedchem.5c02932
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.325 Å)
Structure validation

254917

PDB entries from 2026-06-10

PDB statisticsPDBj update infoContact PDBjnumon